---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-006049"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2026-08-06T20:06:24+00:00"
generated_at: "2026-08-06T20:08:39.396889+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Valion Bio achieves first milestone under Statera license; issues preferred shares for $750K payment

## Summary
- Achieved first milestone: validation of inventory for distribution and sales, triggering $750K payment.
- Issued 1,287.8685 Series A Preferred shares to Statera and Avenue as partial consideration.
- Milestone relates to Entolimod for Acute Radiation Syndrome (ARS) under A&R License Agreement.
- Remaining ARS milestones total $1.75M; Neutropenia milestones up to $2.75M if option exercised.
- Securities issued as unregistered, exempt under Section 4(a)(2) and Regulation D.

## SEC filing metadata
- accession: 0001683168-26-006049
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2026-08-06T20:06:24+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 8.01, 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000168316826006049/0001683168-26-006049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000168316826006049/valion_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-006049
- JSON: https://secwatch.observer/filing/0001683168-26-006049.json
- Plain text: https://secwatch.observer/filing/0001683168-26-006049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.